ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,819.10
0.78%
S&P ASX All Technology
3,330.90
0.60%
Brent Oil
67.075
0.00%
US Dollar vs AUD
1.56535
0.00%
Bitcoin
85,172.20
0.81%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sutro Biopharma Inc (STRO) Share Price

Sutro Biopharma Inc

Sutro Biopharma Inc (STRO)

NASDAQ
0.5246
-0.0154
(-2.85%)
Closed 19 April 6:00AM
Delayed by 15 minutes
0.5395
0.0149
(2.84%)
After Hours: 9:59AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.5246
Bid
0.523
Offer
0.5555
Volume
1,337,203
0.5231 Day's Range 0.5699
0.53295 52 Week Range 5.17
Market Cap
43.949M
Previous Close
0.54
Open
0.54
Last Trade
5
@
0.5555
Last Trade Time
Financial Volume
US$ 731,185
VWAP
0.546802
Average Volume (3m)
1,461,467
Shares Outstanding
83,775,336
Dividend Yield
-
PE Ratio
-0.20
Earnings Per Share (EPS)
-2.72
Revenue
62.04M
Net Profit
-227.46M

About Sutro Biopharma Inc

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.sutrobio.com
Headquarters
South San Francisco, California, USA
Founded
-
Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was US$0.54. Over the last year, Sutro Biopharma shares have traded in a share price range of US$ 0.53295 to US$ 5.17.

Sutro Biopharma currently has 83,775,336 shares in issue. The market capitalisation of Sutro Biopharma is US$45.24 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -0.20.

Ask ADVFN Intelligence (AI)

STRO Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
16 April 2025
STRO (-2.85%)

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
15 April 2025
STRO (-2.85%)

Form 8-K - Current report
Edgar (US Regulatory)
15 April 2025
STRO (-2.85%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 April 2025
STRO (-2.85%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 April 2025
STRO (-2.85%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 April 2025
STRO (-2.85%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 April 2025
STRO (-2.85%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 April 2025
STRO (-2.85%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0772-12.82818212030.60180.6440.5329511320850.57515035CS
4-0.2879-35.43384615380.81250.8530.5329513763270.66973324CS
12-1.4754-73.7722.150.5329514614671.10333439CS
26-3.2654-86.15831134563.794.60.5329511918121.70835975CS
52-3.4154-86.68527918783.945.170.532959514742.52185053CS
156-6.7354-92.77410468327.268.720.532957459403.93643375CS
260-9.9254-94.979904306210.4528.30.532956025957.26522358CS

STRO - Frequently Asked Questions (FAQ)

What is the current Sutro Biopharma share price?
The current share price of Sutro Biopharma is US$ 0.5246
How many Sutro Biopharma shares are in issue?
Sutro Biopharma has 83,775,336 shares in issue
What is the market cap of Sutro Biopharma?
The market capitalisation of Sutro Biopharma is USD 45.24M
What is the 1 year trading range for Sutro Biopharma share price?
Sutro Biopharma has traded in the range of US$ 0.53295 to US$ 5.17 during the past year
What is the PE ratio of Sutro Biopharma?
The price to earnings ratio of Sutro Biopharma is -0.2
What is the cash to sales ratio of Sutro Biopharma?
The cash to sales ratio of Sutro Biopharma is 0.72
What is the reporting currency for Sutro Biopharma?
Sutro Biopharma reports financial results in USD
What is the latest annual turnover for Sutro Biopharma?
The latest annual turnover of Sutro Biopharma is USD 62.04M
What is the latest annual profit for Sutro Biopharma?
The latest annual profit of Sutro Biopharma is USD -227.46M
What is the registered address of Sutro Biopharma?
The registered address for Sutro Biopharma is 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
What is the Sutro Biopharma website address?
The website address for Sutro Biopharma is www.sutrobio.com
Which industry sector does Sutro Biopharma operate in?
Sutro Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
US$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
US$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
US$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
US$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
US$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
US$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
US$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
US$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
US$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
US$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
US$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
US$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
US$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
US$ 8.205
(43.70%)
266.91M

STRO Discussion

View Posts
FALCON1 FALCON1 1 week ago
Excellent time to seek "Defensive Stocks" due to economic headwinds caused by tariffs.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176042856

ELTP, an otc gem on the verge of M&A...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175821245
👍️0
Invest-in-America Invest-in-America 4 months ago
STRO: I launched this new iHub board today due to the below-pasted reply I got from GOOGLE's (AI) search routine regarding my following question: "Which (under $5.00) NASDAQ stock is the most likely to SOAR hugely in price on 1-2-25?"

"According to current market analysis, Sutro Biopharma Inc. (STRO), a clinical-stage biopharmaceutical company currently trading under $5, is considered a potential candidate for a significant price jump due to its promising cancer treatment pipeline, particularly its lead drug candidate "luveltamab tazevibulin" currently in mid-phase trials, which could lead to substantial investor interest if clinical trials prove successful; however, investing in any penny stock carries high risk and should be done with thorough research and consideration of potential downsides."

/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
And "TipRanks" gives STRO a "Strong Buy" rating, for what that's worth. (But its Float is 76-Million, which ain't small.)
👍️0

Your Recent History

NASDAQ
STRO
Sutro Biopharma
NASDAQ
FDPVX
Bmo Global Reit Fund Ser...
NASDAQ
FDELX
Bmo Diversified Income P...
NASDAQ
FDPNX
Bmo Global Quality Etf F...
TG
SSG4
SPDR Series
NASDAQ
CDPYX
Ci Global Equity & Incom...
NASDAQ
FCVJX
Bmo Balanced Etf Portfol...
NASDAQ
CFFDX
Ci Mosaic Esg Balanced E...
NASDAQ
FFDCX
Brandes Global Equity Fu...
BOV
PLPL3
Plano & Plano Desenvolvi... ON
NASDAQ
CCYLX
Ci Emerging Markets Corp...
NASDAQ
CABSX
Caldwell Us Dividend Adv...
BIT
NSCIT5473268
Igloo SPV
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads